I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5
SHANGHAI, Jan. 22, 2019 /PRNew…
The Art & Science of Wellness
SHANGHAI, Jan. 22, 2019 /PRNew…
CHENGDU, China, Jan. 23, 2019 …
BEIJING, Jan. 22, 2019 /PRNews…
TOKYO, Jan. 22, 2019 /PRNewswi…
The U.S. FDA grants an orphan …
Walk for good health, walk for…
多语言WordPress ,采用WPML